GE HealthCare Technologies (GEHC) Total Non-Current Liabilities (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Total Non-Current Liabilities came in at $23.9 billion in Q2 2026, up 1.49% YoY from $23.5 billion in Q2 2025, and down 1.31% on a QoQ basis from $24.2 billion in Q1 2026.
GE HealthCare Technologies (GEHC) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of Total Non-Current Liabilities data on file, last reported at $23.9 billion in Q2 2026.
- Quarterly Total Non-Current Liabilities rose 1.49% year-over-year to $23.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $23.9 billion (up 1.49% YoY) and the FY2025 annual result came in at $24.2 billion, up 7.09% from the prior year.
- Total Non-Current Liabilities fell to $23.9 billion in Q2 2026, from $24.2 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $24.2 billion in Q4 2025 to a low of $16.3 billion in Q4 2022.
- A 5-year average of $22.9 billion and a median of $23.3 billion in 2023 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Non-Current Liabilities surged 42.36% — and 2024, when it dropped 4.63%.
- Tracing GEHC's Total Non-Current Liabilities over 5 years: stood at $16.3 billion in 2022, then surged by 42.36% to $23.3 billion in 2023, then dropped by 2.69% to $22.6 billion in 2024, then grew by 7.09% to $24.2 billion in 2025, then fell by 1.45% to $23.9 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $23.9 billion (Q2 2026), $24.2 billion (Q1 2026), and $24.2 billion (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Zimmer Biomet Holdings | 19.38 Bn | 18.97 Bn | 1.54 Bn | 9.53 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.89 Bn |
| Mar 31, 2026 | 24.21 Bn |
| Dec 31, 2025 | 24.25 Bn |
| Sep 30, 2025 | 23.81 Bn |
| Jun 30, 2025 | 23.54 Bn |
| Mar 31, 2025 | 22.33 Bn |
| Dec 31, 2024 | 22.64 Bn |
| Sep 30, 2024 | 23.42 Bn |
| Jun 30, 2024 | 22.06 Bn |
| Mar 31, 2024 | 22.80 Bn |
| Dec 31, 2023 | 23.27 Bn |
| Sep 30, 2023 | 23.25 Bn |
| Jun 30, 2023 | 23.06 Bn |
| Mar 31, 2023 | 23.91 Bn |
| Dec 31, 2022 | 16.34 Bn |